[e-drug] Which 39 companies are suing Sth Africa?(2)

E-drug: Which 39 companies are suing Sth Africa?(2)
---------------------------------------------
I have just found the answer to my own question on the MSF website:

The 39 companies are:

The Pharmaceutical Manufacturers' Association of South Africa
Alcon Laboratories (S.A.) (Proprietary) Limited
Bayer (Proprietary) Limited
Bristol-Myers Squibb (Proprietary) Limited
Byk Madaus (Proprietary) Limited
Eli Lilly (South Africa) (Proprietary) Limited
Glaxo Wellcome (South Africa) (Proprietary) Limited
Hoechst Marion Roussel Limited
Ingelheim Pharmaceuticals (Proprietary) Limited
Janssen-Cilag Pharmaceutica (Proprietary) Limited
Knoll Pharmaceuticals South Africa (Proprietary) Limited
Lundbeck South Africa (Proprietary) Limited
Merck (Proprietary) Limited
MSD (Proprietary) Limited
Novartis South Africa (Proprietary) Limited
Novo Nordisk (Proprietary) Limited
Pharmacia & Upjohn (Proprietary) Limited
Rhone-Poulenc Rorer South Africa (Proprietary) Limited
Roche Products (Proprietary) Limited
Schering (Proprietary) Limited
Schering-Plough (Proprietary) Limited
S.A. Scientific Pharmaceuticals (Proprietary) Limited
SmithKline Beecham Pharmaceuticals (Proprietary) Limited
Universal Pharmaceuticals (Proprietary) Limited
Wyeth (Proprietary) Limited
Xixia Pharmaceuticals (Proprietary) Limited
Zeneca South Africa (Proprietary) Limited
Bayer AG
Boehringer-Ingelheim International GmbH
Boehringer-Ingelheim KG
Bristol-Myers Squibb Company
Byk Gulden Lomberg Chemische Fabrik GmbH
Dr. Karl Thomae GmbH
Eli Lilly and Company
F. Hoffman-La Roche AG
Merck KGaA
Merck & Co., Inc.
Rhone-Poulenc Rorer S.A.
SmithKline Beecham

regards,

Peter

Dr Peter Mansfield
GP and consultant on marketing and appropriate therapeutics
peter.mansfield@flinders.edu.au
www.malam.asn.au
PO Box 172 Daw Pk SA 5041 Australia
ph/fax +61 8 8374 2245
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.